In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent

被引:56
作者
Hama, Yukihiro
Urano, Yasuteru
Koyama, Yoshinori
Kamiya, Mako
Bernardo, Marcelino
Paik, Ronald S.
Krishna, Murali C.
Choyke, Peter L.
Kobayashi, Hisataka
机构
[1] NCI, NIH, Mol Imaging Program, Canc Res Ctr, Bethesda, MD 20892 USA
[2] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[3] NCI, Radiat Biol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA
来源
NEOPLASIA | 2006年 / 8卷 / 07期
关键词
metastasis; optical imaging; ovarian cancer; target imaging; microfoci;
D O I
10.1593/neo.06268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intraperitoneal metastases commonly recur after surgery because small tumor foci escape detection within the complex anatomy of the peritoneal cavity and mesentery. Accurate localization of peritoneal implants during surgery could improve the resection of ovarian cancer and other malignancies, but few practical techniques to enhance detectability are currently available. Here, we describe a targeted molecular imaging method that employs fluorescently labeled avidin to detect submillimeter peritoneal implants of ovarian cancer in mice. After binding to surface lectins on the tumor, fluorescein-conjugated avidin enabled the spectral fluorescence imaging of disseminated peritoneal implants. High spatial resolution and high tumor-to-background ratio allowed the visualization of implants as small as 0.3 mm ( with 100% sensitivity and specificity; n = 150) and the identification of even smaller lesions ex vivo. These results suggest that targeted molecular imaging with a fluorescence-labeled lectin-ligand system is a promising technique for the detection of disseminated submillimeter foci of cancer.
引用
收藏
页码:607 / U2
页数:8
相关论文
共 20 条
[1]   White-light toxicity, resulting from systemically administered 5-aminolevulinic acid, under normal operating conditions [J].
Aalders, MCG ;
Van der Vange, N ;
Stewart, FA ;
Klein, MG ;
Van der Vijver, MJ ;
Sterenborg, HJCM .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1999, 50 (2-3) :88-93
[2]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[3]   Optical-based molecular imaging: contrast agents and potential medical applications [J].
Bremer, C ;
Ntziachristos, V ;
Weissleder, R .
EUROPEAN RADIOLOGY, 2003, 13 (02) :231-243
[4]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[5]   The present and future role of photodynamic therapy in cancer treatment [J].
Brown, SB ;
Brown, EA ;
Walker, I .
LANCET ONCOLOGY, 2004, 5 (08) :497-508
[6]  
Ciardella Antonio P, 2004, Curr Opin Ophthalmol, V15, P519
[7]  
GABIUS HJ, 1986, ANTICANCER RES, V6, P573
[8]  
IMAI S, 1990, ONCOLOGY, V47, P177
[9]   Cancer statistics, 2004 [J].
Jemal, A ;
Tiwari, RC ;
Murray, T ;
Ghafoor, A ;
Samuels, A ;
Ward, E ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) :8-29
[10]   APPLICATION OF HIGH-AFFINITY BINDING CONCEPT TO RADIOLABEL AVIDIN WITH TC-99M LABELED BIOTIN AND THE EFFECT OF PI ON BIODISTRIBUTION [J].
JEONG, JM ;
KINUYA, S ;
PAIK, CH ;
SAGA, T ;
SOOD, VK ;
CARRASQUILLO, JA ;
NEUMANN, RD ;
REYNOLDS, JC .
NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (07) :935-940